期刊文献+

疏肝健脾方对乳腺增生大鼠sFas及Fas/FasL表达的干预作用 被引量:6

Intervention Effects of Liver-smoothing and Spleen-strengthening Formula on sFas and Fas/Fasl Expression of Hyperplasia Histology of Mammary Gland in Rats
下载PDF
导出
摘要 目的观察疏肝健脾方对乳腺增生大鼠血清sFas、乳腺组织Fas、FasL的影响。方法 60只大鼠随机分为空白对照组、疾病模型组、三苯氧胺组、疏肝健脾方小剂量组、疏肝健脾方大剂量组5组,每组12只,采用苯甲酸雌二醇和黄体酮肌注造模的同时,分别以蒸馏水、三苯氧胺、疏肝健脾方灌胃干预治疗30天后,观察乳腺增生大鼠血清sFas浓度和乳腺组织Fas、FasL的表达。结果 Fas在乳腺增生病模型大鼠中表达较低,FasL表达较高,经药物干预后,均能够增加Fas在乳腺组织中的表达(P<0.01),降低FasL中的表达(P<0.01),接近空白对照组,各组药物之间无显著性差异(P>0.05)。sFas在大鼠乳腺增生病模型血清中的浓度增高,经药物干预后能够降低sFas在大鼠血清中的浓度(P<0.01或0.05),各药物组之间无显著性差异(P>0.05)。结论疏肝健脾方对大鼠乳腺增生组织Fas/FasL系统有显著的干预作用,通过提高Fas降低FasL蛋白的表达,降低sFas在大鼠血清中的浓度,从而抑制/逆转乳腺增生,降低增生程度。 Objective To detect the effects of liver - smoothing and spleen - strengthening formula(LSF) on sFas and Fas/Fasl expression of hyperplasia histology of mammary gland(HMG) in rats. Methods 60 rats were divided into 5 groups at random with 12 rats in each group:blank control group, disease model group, tamoxifen group, LSF low dose group and LSH high dose group. Rats were injected with benzestrofol and progesterone to establish the HMG model. Meanwhile, every rat was administrated pure water, tamoxifen, low - dose LSF and high - dose LSF respectively once a day. At the 30th day, sFas concentration and Fas/Fsal expression level of HMG were observed. Result It was lower expression level of Fas and higher expression level of Fasl in the HMG model group. After those dugs were administrated respectively, there was increase in the expression level of Fas(P 〈 0.01 ) and decrease in the expression level of Fasl(P 〈 0.01 ), which was approximate to the blank control group. No significant difference existed among drug groups(P 〉 0.05 ). It was higher for sFas in HMG model group and after the intervention of the drugs, and sFas concentration was decreased (P 〈 0. 01 or P 〈 0. 05 ). Conclusion LSF can have significant intervention effects on Fas/Fasl system of HMG in rats, and cut down/reverse the hyperplasia of mam- mary gland by improving the expression level of Fas and degrade the expression level of Fasl and the concentration of sFas.
作者 李湘奇
出处 《医学研究杂志》 2011年第1期89-92,共4页 Journal of Medical Research
基金 山东省中医药科技发展计划项目(2007-166)
关键词 疏肝健脾方 乳腺增生病 SFAS FAS FASL Liver - smoothing and spleen - strengthening formula Hyperplasia of mammary gland sFas Fas Fasl
  • 相关文献

参考文献5

二级参考文献21

  • 1李湘奇,宫少波,魏芳.乳癖康合剂对乳腺增生病大鼠血清性激素及乳腺组织血管内皮生长因子、微血管密度表达的影响[J].北京中医药大学学报(中医临床版),2005,12(5):1-3. 被引量:19
  • 2郑德先.细胞凋亡的研究进展[J].中华病理学杂志,1996,25(1):50-53. 被引量:47
  • 3Galand P. Cyclin/PCNA immunostaining as an alternative totritiated thymidine pulse labelling for marking S phase cells in paraffin sections from animal and human tissues[J ]. Cell Tissue Kinet, 1989,22: 338.
  • 4Ferguson DJD,Anderson TJ. Morphological evaluation of cell turnover in relation to the menstrual cycle in the resting human breast[J]. BrJ Cancer, 1981,44(2):177.
  • 5Easton DF, Ford D, Bishop DT et al.Breast and ovarian cancer incidence in BRCA1 - mutation carriers: breast cancer linkage consortium. AM J Hum C, enet, 1995, 56 (1):265-271
  • 6Malone KE, Daling JR, Thompson JD et al.BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first - degree family history. JAMA, 1998, 279 (12): 922-929
  • 7Szbo CI, King MC. Population genetics of BRCA1 and BRCA2. Am J Hum Genet, 1997, 60 (5) : 1013 -1020
  • 8Wong GHW,Goeddel DV.Fas antigen and P55 TNF receptorsignal apoptosis through distinct pathways[J].J Immunol,1994; 152:1751.
  • 9Kerr J FR,Winterford CM,Harmon BV.Apoptosis:its significance in cancer and cancer therapy[J].Cancer,1994;73:2013.
  • 10Baryon RC,Daniel Pr,Mapara MY,et al.Expression of the bcl-gene family in normal and malignant breast tissue:low bax-aexpression intumor cells correlate with resistance towards apoptosis[J].Int J Cancer,1995;60(6):854.

共引文献130

同被引文献82

引证文献6

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部